Free Trial

Jushi (OTCMKTS:JUSHF) Stock Price Down 2.3% - Should You Sell?

Jushi logo with Medical background

Key Points

  • Jushi Holdings Inc. shares fell by 2.3% during trading, reaching a low of $0.56 and last trading at $0.64.
  • The company reported a revenue of $65.05 million for the quarter, slightly exceeding the consensus estimate of $64.67 million.
  • Jushi has a market capitalization of $124.88 million and a negative P/E ratio of -2.19, indicating potential financial struggles.
  • Interested in Jushi? Here are five stocks we like better.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report)'s stock price traded down 2.3% on Wednesday . The company traded as low as $0.56 and last traded at $0.64. 560,999 shares traded hands during mid-day trading, an increase of 48% from the average session volume of 379,166 shares. The stock had previously closed at $0.65.

Jushi Price Performance

The firm has a market cap of $133.10 million, a PE ratio of -2.33 and a beta of -0.98. The company has a 50 day simple moving average of $0.40 and a 200-day simple moving average of $0.35.

Jushi (OTCMKTS:JUSHF - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The company had revenue of $65.05 million during the quarter, compared to analysts' expectations of $64.67 million. On average, sell-side analysts predict that Jushi Holdings Inc. will post -0.23 EPS for the current fiscal year.

About Jushi

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

See Also

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines